@incollection{, 9A333A8C4D677D5ADCB9D1C5C7192E8B , author={{Jignakumari J.Gohil} and {Chiragkumar J.Gohil}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}2113137 } @incollection{b0, , title={{Novel Corona Virus and Its Druggable Targets}} , author={{ CJGohil } and { MNNoolvi }} , journal={{Curr Opin Virus Infect Dis}} 1 3 , year={2020} } @incollection{b1, , title={{Clinical Characteristics of 138 Hospitalized Patients With 2019Novel Coronavirus-Infected Pneumonia in Wuhan, China}} , author={{ DWang } and { BHu } and { CHu }} , journal={{JAMA}} 323 , year={2020} } @incollection{b2, , title={{Corona Is Culprit of Ridiculous Offensive Nonsense Air}} , author={{ DJSen } and { SKMandal } and { ABiswas } and { DDastider } and { BMahanti }} , journal={{World J Pharm Res}} 9 , year={2020} } @incollection{b3, , title={{The trinity of COVID-19: immunity, inflammation and intervention}} , author={{ MZTay } and { CMPoh } and { LRenia } and { PAMacary } and { LfpNg }} , journal={{Nat Rev Immunol}} , year={2020} } @incollection{b4, , title={{Dysregulation of immune response in patients with Coronavirus}} , author={{ CQin } and { LZhou } and { ZHu } and { SZhang } and { SYang } and { YTao } and { CXie } and { KMa } and { KShang } and { Wang Tian Ds }} COVID-19 , journal={{Clin Infect Dis}} 71 , year={2019. 2020} } @incollection{b5, , title={{The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19}} , author={{ QYe } and { BWang } and { JMao }} , journal={{J Infect}} 80 , year={2020} } @incollection{b6, , title={{An interferon-gamma-related cytokine storm in SARS patients}} , author={{ KJHuang } and { JSui } and { MTheron } and { YCWu } and { SKLai } and { CCLiu } and { HYLei }} , journal={{J Med Virol}} 75 , year={2005} } @incollection{b7, , title={{Drug targets for corona virus: A systematic review}} , author={{ MPrajapat } and { PSarma } and { NShekhar } and { PAvti } and { SSinha } and { HKaur } and { SKumar } and { ABhattacharyya } and { HKumar } and { SBansal } and { BMedhi }} , journal={{Indian J Pharmacol}} 52 , year={2020} } @incollection{b8, , title={{Human infection by avian influenza A H5N1}} , author={{ KYYuen } and { SSWong }} , journal={{Hong Kong Med J}} 11 , year={2005} } @incollection{b9, , title={{The cytokine storm in COVID-19: An overview of the involvement of the chemokine /chemokine-receptor system}} , author={{ FCoperchinia } and { LChiovatoa } and { LCrocea } and { FMagria } and { MRotondia }} , journal={{Cytokine Growth Factor Rev}} 53 , year={2020} } @incollection{b10, , title={{Is a "Cytokine Storm" Relevant to COVID-19?}} , author={{ PSinha } and { MAMatthay } and { CSCalfee }} , journal={{JAMA Intern Med}} , year={2020} } @incollection{b11, , title={{Immunity to viruses}} , author={{ Bracialet } and { YHahn }} , journal={{Immunol Rev}} 255 , year={2013} } @incollection{b12, , title={{Pattern recognition receptors and the innate immune response to viral infection}} , author={{ MThompson } and { JKaminski } and { EKurt-Jones } and { KFitzgerald }} , journal={{Viruses}} 3 , year={2011} } @incollection{b13, , title={{Itolizumab, an anti-CD6 monoclonal antibody, as apotential treatment for COVID-19 complications}} , author={{ SLoganathan } and { SNAthalye } and { SRJoshi }} , journal={{Expert Opin Biol Ther}} , year={2020} } @incollection{b14, , title={{Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations}} , author={{ YMehta } and { SBDixit } and { KGZirpe } and { ASAnsari }} , journal={{Indian J Crit Care Med}} 24 , year={2020} } @incollection{b15, , title={{Middle East Respiratory Syndrome: An Overview}} , author={{ MSPrarthana } and { SKalagi }} , journal={{Int J Health Sci Res}} 5 , year={2015} } @incollection{b16, , title={{The COVID-19 Cytokine Storm; WhatWe Know So Far}} , author={{ DRagab } and { Eldinhs } and { Taeimahm } and { RKhattab } and { RSalem }} , journal={{Front Immunol}} 11 , year={2020} } @book{b17, , title={{COVID-19 and the Cytokine Storm: The Crucial Role of IL-6. Enzo life sciences}} , author={{ Technotes }} 2020 , note={cited} } @incollection{b18, , title={{Immunological and inflammatory functions of the interleukin-1 family}} , author={{ CADinarello }} , journal={{Annu Rev Immunol}} 27 , year={2009} } @incollection{b19, , title={{Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection}} , author={{ NSchmitz } and { MKurrer } and { MFBachmann } and { MKopf }} , journal={{J Virol}} 79 , year={2005} } @incollection{b20, , title={{Into the Eye of the Cytokine Storm}} , author={{ JRTisoncik } and { MJKorth } and { CPSimmons } and { JFarrar } and { TRMartin } and { MGKatzea }} , journal={{Mol Biol Rev}} 76 , year={2012} } @book{b21, , title={{Cytokine Storms May Be Fueling Some COVID Deaths. WebMD Health News}} , author={{ BGoodman }} , note={cited 2020 Sep 22} } @incollection{b22, , title={{Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies}} , author={{ MZhao }} , journal={{Int J Antimicrob Agents}} 55 , year={2020} } @incollection{b23, , title={{Preventing 'cytokine storm' may ease severe COVID-19 symptoms. Howard Hughes Medical Institute}} , journal={{Science News}} 17 , year={November 2020} } @incollection{b24, , title={{COVID-19 and lung pathology}} , author={{ AJain }} , journal={{Indian J Pathol Microbiol}} 63 , year={2020} } @incollection{b25, , title={{Clinical preparedness for cytokine storm induced by the highly pathogenic H5N1 influenza virus}} , author={{ TIshikawa }} , journal={{J Pharmacogenom Pharma coproteomics}} 3 , year={2012} } @incollection{b26, , title={{Highly pathogenic avian influenza H5N1 virus induces cytokine dysregulation with suppressed maturation of chicken monocyte-derived dendritic cells}} , author={{ SKalaiyarasu } and { MKumar } and { DSenthil Kumar } and { SBhatia } and { SKDash } and { SBhat }} , journal={{Microbiol Immunol}} 60 , year={2016} } @incollection{b27, , title={{Inhibition of Bruton tyrosine kinase in patients with severe COVID-19}} , author={{ MRoschewski } and { MSLionakis } and { JPSharman }} 10.1126/sciimmunol.abd0110 , journal={{Sci Immunol}} 5 48 , year={2020} } @incollection{b28, , title={{Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review}} , author={{ JAlijotas-Reig } and { EEsteve-Valverde } and { CBelizna } and { ASelva-O'callaghan } and { JPardos-Gea } and { AQuintana } and { AMekinian } and { AMiro-Mur } and { F }} 10.1016/j.autrev.2020.102569 , journal={{Autoimmun Rev}} 19 , year={2020} } @incollection{b29, , title={{Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology}} , author={{ ESchrezenmeier } and { TDorner }} , journal={{Nat Rev Rheumatol}} 16 , year={2020} } @incollection{b30, , title={{New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?}} , author={{ CADevaux } and { JMRolain } and { PColson } and { DRaoult }} 10.1016/j.ijantimicag.2020.105938 , journal={{Int J Antimicrob Agents}} 55 , year={2020} } @incollection{b31, , title={{Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China}} , author={{ QRuan } and { KYang } and { WWang } and { LJiang } and { JSong }} , journal={{Intensive Care Med}} 46 , year={2020} }